NWN, a leading AI-powered technology services provider and Palo Alto Networks NextWave Diamond Innovator, today announced that it has earned three Palo Alto Networks NextWave Advanced Specializations ...

Sept 22 (Reuters) - Palo Alto Networks (PANW.O), opens new tab said on Tuesday it would launch a new cybersecurity service for businesses, using advanced AI ‌models from Anthropic and OpenAI to help ...

We analyzed more than 2 million speed tests alongside price, coverage, and customer satisfaction data to rank every major wireless carrier and MVNO in 49 states, 19 major cities, and nationwide.

Discover how 5G‑Advanced network upgrades in 2026 improve latency, network slicing, and fixed wireless access to make phones, cars, and home internet more responsive and reliable. Pixabay, ...

Palo Alto Networks topped Wall Street's third-quarter estimates, citing AI advancements The rise of advanced AI models like Mythos has drawn attention to cyber companies and the need for better ...

Section 1. Purpose. The United States continues to lead the world in Artificial Intelligence (AI) because of the enormous talent and innovation of our AI industry, and because we refuse to stifle this ...

Researchers at the University of Toronto showed how hackers could use artificial intelligence to create a program that could target any known flaw in the world’s computers. By Cade Metz Cade Metz has ...

Extreme Networks is adding new AI agent software to its product portfolio, making significant upgrades to its Platform ONE management package, and extending its Wi-Fi 7 portfolio. In the big picture, ...

One of the telltale signs that your computer has been compromised is unexplained slowdowns and constant background activity — even when you’re not using your computer. Additionally, look out for ...

Researchers at Cornell University have developed a powerful imaging technique that reveals atomic scale defects inside computer chips for the first time. Using an advanced electron microscopy method, ...

First results of a dose-escalation study evaluating Clostridium butyricum MIYAIRI 588 (CBM588) with nivolumab/ipilimumab (nivo/ipi) in metastatic renal cell carcinoma (mRCC). This is an ASCO Meeting ...